Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer

• Publication date

  1999-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0142(19991115)86:10<1976::AID-CNCR14>3.0.CO;2-IPMID 10570421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Young lung cancer patients in Japan: different characteristics between the sexes.

  1999cited by this paper
• Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer.

  1999cited by this paper
• Association between Smoking and Tumor Progression in Japanese Women with Adenocarcinoma of the Lung

  1999cited by this paper
• Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.

  1998cited by this paper
• "Incomplete resection" in non-small cell lung cancer: need for a new definition. Canadian Lung Oncology Group.

  1998cited by this paper
• Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer

  1998cited by this paper
• Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung.

  1998cited by this paper
• Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin.

  1998cited by this paper
• Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer.

  1998cited by this paper
• KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor

  1998cited by this paper
• Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.

  1997cited by this paper
• Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.

  1997cited by this paper
• Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer : prognostic significance

  1997cited by this paper
• Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases

  1997cited by this paper
• Immunohistochemically detected expression of motility‐related protein‐1 (MRP‐1/CD9) in lung adenocarcinoma and its relation to prognosis

  1997cited by this paper
• Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer.

  1997cited by this paper
• Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma.

  1997cited by this paper
• Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.

  1996cited by this paper
• Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer.

  1996cited by this paper
• Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer.

  1996influential reference
• Chest wall invasive non-small cell lung cancer: Patterns of failure and implications for a revised staging system

  1996cited by this paper
• Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.

  1996cited by this paper
• Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.

  1996cited by this paper
• Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.

  1995cited by this paper
• Incidence of local recurrence and second primary tumors in resected stage I lung cancer.

  1995cited by this paper
• Stage I nonsmall cell lung cancer : a multivariate analysis of treatment methods and patterns of recurrence

  1995cited by this paper
• Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage.

  1995influential reference
• Small adenocarcinoma of the lung. Histologic characteristics and prognosis

  1995cited by this paper
• Surgically Curable “Early” Adenocarcinoma in the Periphery of the Lung

  1994influential reference
• Results of surgical resection in patients with N2 non-small cell lung cancer.

  1994cited by this paper
• Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes.

  1994cited by this paper
• Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer.

  1994cited by this paper
• Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: A prospective study

  1994cited by this paper
• Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease).

  1994cited by this paper
• Primary lung cancer invading the chest wall.

  1994cited by this paper
• Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.

  1993cited by this paper
• Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer.

  1993cited by this paper
• Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.

  1993cited by this paper
• Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.

  1993cited by this paper
• Prognostic Factors in Lung Cancer Based on Multivariate Analysis

  1993cited by this paper
• Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.

  1993influential reference
• Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.

  1993cited by this paper
• Survival after resection of stage II non-small cell lung cancer.

  1992cited by this paper
• Importance of microscopic residual disease at the bronchial margin after resection for non-small-cell carcinoma of the lung.

  1992cited by this paper
• ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.

  1992cited by this paper
• Prognostic significance of computed tomography in resected N2 lung cancer.

  1992cited by this paper
• Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung.

  1992cited by this paper
• ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.

  1991cited by this paper
• The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung. A commentary.

  1990cited by this paper
• K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.

  1990cited by this paper
• DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma

  1989cited by this paper
• Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence.

  1989cited by this paper
• An ecogenetic hypothesis for lung cancer in women.

  1988cited by this paper
• Relationship between cigarette smoking and histologic type of lung cancer, with special reference to sex difference.

  1988cited by this paper
• The role of surgery in N2 lung cancer.

  1987cited by this paper
• Postoperative T1 N0 non-small cell lung cancer. Squamous versus nonsquamous recurrences. The Lung Cancer Study Group.

  1987cited by this paper
• Smoking history and lung cancer survival in women.

  1982cited by this paper
• Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.

  1982cited by this paper
• Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers

  1980cited by this paper
• Results of surgical treatment in Stage I lung cancer.

  1977cited by this paper
• The analysis of binary data

  1971cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Prognostic ımpact of vascular, lymphatic, and perineural ınvasion in surgically resected, non-adjuvantly treated stage IA non-small-cell lung cancer: a retrospective cohort study.

  2026cites this paper
• Clinicopathologic study of stage I adenosquamous carcinoma of the lung.

  2023cites this paper
• A two-step feature selection procedure for relevant markers of Squamous Cell Lung Carcinoma using different survival models

  2023cites this paper
• COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease

  2021cites this paper
• Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?

  2021cites this paper
• Morbidity, mortality and survival rates of non-small cell lung cancer patients who underwent lobectomy with pulmonary artery reconstruction compared to those of the patients who underwent pneumonectomy

  2020cites this paper
• Cyclin-dependent kinase 6 (CDK6) is a candidate diagnostic biomarker for early non-small cell lung cancer

  2020cites this paper
• Is the prognostic nutritional index (PNI) a useful predictive marker for postoperative complications after lung surgery?

  2019cites this paper
• Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma

  2019cites this paper
• Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer

  2018cites this paper
• Computer-assisted subtyping and prognosis for non-small cell lung cancer patients with unresectable tumor

  2018cites this paper
• Construction of a transcription factor-long non-coding RNA-microRNA network for the identification of key regulators in lung adenocarcinoma and lung squamous cell carcinoma

  2018cites this paper
• The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates

  2018cites this paper
• Discriminating lung adenocarcinoma from lung squamous cell carcinoma using respiration-induced tumor shape changes

  2018cites this paper
• Prognostic factors for surgically resected non-small cell lung cancer with cavity formation.

  2018cites this paper
• Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non–Small‐cell Lung Cancer

  2018influential citation
• The diffusing capacity of the lung for carbon monoxide is associated with the histopathological aggressiveness of lung adenocarcinoma†

  2017cites this paper
• Gender differences in the correlation between prognosis and postoperative weight loss in patients with non-small cell lung cancer.

  2017cites this paper
• Prognostic impact of lymphovascular invasion on TNM staging in stage I non-small-cell lung cancer

  2017cites this paper
• ifferences in the prognostic implications of vascular invasion etween lung adenocarcinoma and squamous cell carcinoma

  2016cites this paper
• Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma

  2015influential citation
• Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients

  2015cites this paper
• The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer

  2015cites this paper
• CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis

  2014cites this paper
• Digital differentiation of non-small cell carcinomas of the lung by the fractal dimension of their epithelial architecture.

  2014cites this paper
• Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma

  2014cites this paper
• Prognostic impact of vascular and lymphovascular invasion in early lung cancer

  2014cites this paper
• Prognostic Impact of Microscopic Vessel Invasion and Visceral Pleural Invasion in Non–Small Cell Lung Cancer: A Retrospective Analysis of 2657 Patients

  2014cites this paper
• Bronchology – A Well Branched Tree

  2013cites this paper
• Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.

  2013influential citation
• Chapter 10 Bronchology – A Well Branched Tree

  2013cites this paper
• Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.

  2013cites this paper
• Outcome and prognostic factors of resected non-small-cell lung cancer invading the diaphragm.

  2013cites this paper
• Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?

  2013cites this paper
• Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer

  2013cites this paper
• Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.

  2013cites this paper
• Low Perioperative Serum Prealbumin Predicts Early Recurrence after Curative Pulmonary Resection for Non-Small-Cell Lung Cancer

  2012cites this paper
• T1aN0M0 and T1bN0M0 Non–Small Cell Lung Cancer: A Retrospective Study of the Prognosis

  2012cites this paper
• Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.

  2012cites this paper
• Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.

  2012cites this paper
• Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.

  2012cites this paper
• Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer

  2012cites this paper
• Clinical Significance and Role of Lymphatic Vessel Invasion as a Major Prognostic Implication in Non-Small Cell Lung Cancer: A Meta-Analysis

  2012cites this paper
• Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be?

  2012cites this paper
• Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal?

  2012cites this paper
• Bronchovascular reconstruction for lung cancer: does induction chemotherapy influence the outcomes?

  2012cites this paper
• Clinical Usefulness of D2-40 in Non-Small Cell Lung Cancer

  2011cites this paper
• Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations

  2011cites this paper
• Blood Vessel Invasion as a Strong Independent Prognostic Indicator in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

  2011cites this paper
• A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.

  2011cites this paper
• THE ROLE OF K-ras, p53 AND CLINICOPATHOLOGICAL FACTORS IN SUBSTAGING OF RESECTED PATIENTS WITH pIIIa - N2 NSCLC ULOGA K-ras I p53 GENA, KLINI^KIH I PATOLO(KIH PARAMETARA U SUBSTEJD@INGU OPERISANIH PACIJENATA SA pIIIa - N2 NESITNO)ELIJSKIM KARCINOMOM PLU)A

  2011cites this paper
• Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer.

  2011cites this paper
• VEGF-C antisense oligoxydeonucleotide suppression of invasive ability of the A-549 lung carcinoma cell line.

  2011cites this paper
• Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification.

  2011cites this paper
• Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer

  2011cites this paper
• Prognostic impact of histology on early-stage non-small cell lung cancer.

  2011cites this paper
• Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung Cancers

  2011cites this paper
• Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables

  2011cites this paper
• How close are we to customizing chemotherapy in early non-small cell lung cancer?

  2011cites this paper
• Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients

  2010cites this paper
• Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells

  2010cites this paper
• Very important histopathological factors in patients with resected non-small cell lung cancer: necrosis and perineural invasion.

  2010cites this paper
• Verification of the Newly Proposed T Category (Seventh Edition of the Tumor, Node, and Metastasis Classification) from a Clinicopathological Viewpoint in Non-small Cell Lung Cancer—Special Reference to Tumor Size

  2010cites this paper
• Tumorigenesis and Neoplastic Progression Tumorigenic Role of Orphan Nuclear Receptor NR 0 B 1 in Lung Adenocarcinoma

  2010cites this paper
• Factors associated with the development of brain metastases

  2010cites this paper
• Clinicopathologic features in resected subcentimeter lung cancer--status of lymph node metastases.

  2010cites this paper
• Extratumoral Vascular Invasion Is a Significant Prognostic Indicator and a Predicting Factor of Distant Metastasis in Non-small Cell Lung Cancer

  2010cites this paper
• Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.

  2010cites this paper
• Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.

  2010cites this paper
• Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension.

  2010cites this paper
• Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection.

  2010influential citation
• Prognostic significance of heat shock protein 105 in lung adenocarcinoma.

  2009cites this paper
• Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non‐small cell lung carcinoma

  2009cites this paper
• Clinical Impact of Endoscopic Ultrasound-Fine Needle Aspiration of Left Adrenal Masses in Established or Suspected Lung Cancer

  2009cites this paper
• Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.

  2009cites this paper
• Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung

  2009cites this paper
• Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.

  2009cites this paper
• Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.

  2009cites this paper
• Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies.

  2009cites this paper
• Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.

  2009cites this paper
• Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.

  2009cites this paper
• Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma.

  2009cites this paper
• Clinical significance of vascular endothelial growth factors (VEGF)-C and -D in resected non-small cell lung cancer.

  2008cites this paper
• Predicting Survival in Potentially Curable Lung Cancer Patients

  2008cites this paper
• Prognostic Factors in Resected T3 Non-Small Cell Lung Carcinoma: Perineural Invasion as a New Prognostic Factor

  2008cites this paper
• Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer.

  2008cites this paper
• Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.

  2008cites this paper
• Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.

  2008cites this paper
• The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer.

  2007cites this paper
• Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.

  2007cites this paper
• Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.

  2007cites this paper
• Evaluation of extratumoral lymphatic permeation in non-small cell lung cancer as a means of predicting outcome.

  2007cites this paper
• Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti‐podoplanin or anti‐D2‐40 antibody is correlated with lymphatic invasion or lymph node metastases

  2007cites this paper
• [Is the current TNM classification still the best criterion for choosing treatment for non-small-cell lung cancer?].

  2006cites this paper
• Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.

  2006cites this paper
• Application of subsecond rotation scan to helical CT for lung cancer screening.

  2006cites this paper
• Clinical Prognostic Factors in Non-Small-Cell Lung Cancer

  2006cites this paper
• La classification TNM actuelle reste-t-elle le meilleur critère de choix du traitement du cancer bronchique non à petites cellules ?

  2006cites this paper
• Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.

  2006cites this paper
• The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years.

  2005cites this paper